Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.33 USD | +3.21% | -10.46% | -34.25% |
01:24pm | Guggenheim Upgrades Amicus Therapeutics to Buy From Neutral With $13 Price Target | MT |
10/05 | UBS Trims Price Target on Amicus Therapeutics to $19 From $20, Keeps Buy Rating | MT |
- Stock Market
- Equities
- FOLD Stock
- News Amicus Therapeutics, Inc.